###############################################################
## ULTIMATE PATHWAY LIST - 74 PATHWAYS
## COMPLETE PLATELET BIOLOGY + ALL LIPID SIGNALING
## Includes: PKC, PKA/cAMP, cGMP, AMPK, G-protein
##           + ALL LIPID PATHWAYS (TXA2, S1P, DAG/IP3, etc)
###############################################################

manual_path_refined <- c(
  
  # === CORE PLATELET ACTIVATION & ADHESION (7) ===
  "Platelet activation",
  "Platelet degranulation",
  "Response to elevated platelet cytosolic Ca2+",
  "Platelet Adhesion to exposed collagen",
  "Hemostasis",
  "Platelet calcium homeostasis",
  "Platelet Aggregation (Plug Formation)",
  
  # === ENDOCYTOSIS - KEY FOR ACKR3! (2) ===
  "Clathrin-mediated endocytosis",
  "Cargo recognition for clathrin-mediated endocytosis",
  
  # === INTEGRIN & CELL SIGNALING (3) ===
  "Integrin cell surface interactions",
  "Integrin signaling",
  "Signaling by Receptor Tyrosine Kinases",
  
  # === GPCR & G-PROTEIN SIGNALING (8) ===
  "Signaling by GPCR",
  "GPCR downstream signalling",
  "G beta:gamma signalling through PI3Kgamma",
  "Activation of G protein gated Potassium channels",
  "G beta:gamma signalling through PLC beta",
  "G beta:gamma signalling through BTK",
  "G beta:gamma signalling through CDC42",
  "G protein gated Potassium channels",
  
  # === COLLAGEN/GPVI - SYK-MEDIATED ACTIVATION (1) ===
  "GPVI-mediated activation cascade",
  
  # === FC GAMMA RECEPTOR - IMMUNE (2) ===
  "FCGR activation",
  "Fcgamma receptor (FCGR) dependent phagocytosis",
  
  # === PKA/cAMP SIGNALING (7) ===
  "PKA activation",
  "PKA activation in glucagon signalling",
  "Adenylate cyclase activating pathway",
  "Adenylate cyclase inhibitory pathway",
  "CREB1 phosphorylation through the activation of Adenylate Cyclase",
  "PKA-mediated phosphorylation of CREB",
  "PKA-mediated phosphorylation of key metabolic factors",
  
  # === PKC SIGNALING (1) ===
  "Gastrin-CREB signalling pathway via PKC and MAPK",
  
  # === cGMP/PKG SIGNALING (2) ===
  "cGMP effects",
  "Nitric oxide stimulates guanylate cyclase",
  
  # === AMPK SIGNALING (3) ===
  "Energy dependent regulation of mTOR by LKB1-AMPK",
  "Activation of AMPK downstream of NMDARs",
  "AMPK inhibits chREBP transcriptional activation activity",
  
  # === RAF/MAPK CASCADE (6) ===
  "RAF activation",
  "Signalling to ERKs",
  "ERK/MAPK targets",
  "ERKs are inactivated",
  "Signaling by BRAF and RAF1 fusions",
  "Negative regulation of MAPK pathway",
  
  # === RAS/GRB2 (2) ===
  "GRB2:SOS provides linkage to MAPK signaling for Integrins",
  "Regulation of RAS by GAPs",
  
  # === RHO GTPASE SIGNALING (8) ===
  "Signaling by Rho GTPases",
  "RHOA GTPase cycle",
  "RHOB GTPase cycle",
  "RHOC GTPase cycle",
  "RHOV GTPase cycle",
  "RHO GTPase cycle",
  "RHO GTPase Effectors",
  "RHO GTPases Activate WASPs and WAVEs",
  
  # === ROS/NOX PATHWAY (1) ===
  "RHO GTPases Activate NADPH Oxidases",
  
  # === PI3K/AKT SIGNALING (4) ===
  "PIP3 activates AKT signaling",
  "AKT phosphorylates targets in the cytosol",
  "Negative regulation of the PI3K/AKT network",
  "PI3K Cascade",
  
  # === PHOSPHOLIPID SIGNALING (3) ===
  "Effects of PIP2 hydrolysis",
  "Synthesis of PIPs at the plasma membrane",
  "Phospholipid metabolism",
  
  # === CALCIUM SIGNALING (1) ===
  "Ca-dependent events",
  
  # === METABOLIC SIGNALING (3) ===
  "MTOR signalling",
  "mTORC1-mediated signalling",
  "Amino acids regulate mTORC1",
  
  # === AUTOPHAGY (1) ===
  "Autophagy",
  
  # === NON-RECEPTOR TYROSINE KINASES (1) ===
  "Signaling by Non-Receptor Tyrosine Kinases",
  
  # === PLATELET SPREADING/CYTOSKELETON (1) ===
  "DAP12 signaling",
  
  # === EXTRACELLULAR MATRIX (2) ===
  "Extracellular matrix organization",
  "Degradation of the extracellular matrix",
  
  # === MEMBRANE TRAFFICKING (1) ===
  "Membrane Trafficking",
  
  # === CRITICAL THROMBOXANE PATHWAY (4) â­â­â­ ===
  "Arachidonic acid metabolism",
  "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)",
  "Thromboxane signalling through TP receptor",
  "Eicosanoids",
  
  # === DAG/IP3 SIGNALING & METABOLISM (4) â­â­â­ ===
  "DAG and IP3 signaling",
  "Inositol phosphate metabolism",
  "Synthesis of IP3 and IP4 in the cytosol",
  "Arachidonate production from DAG",
  
  # === SPHINGOLIPID/S1P PATHWAY (3) â­â­â­ CRITICAL! ===
  "Lysosphingolipid and LPA receptors",
  "Ceramide signalling",
  "Sphingolipid metabolism",
  
  # === ADDITIONAL LIPID PATHWAYS (4) â­ ===
  "Eicosanoid ligand-binding receptors",
  "Acyl chain remodeling of DAG and TAG",
  "PLC beta mediated events",
  "Role of phospholipids in phagocytosis"
)

# Remove any duplicates
manual_path_refined <- unique(manual_path_refined)

# ============================================================
# SUMMARY
# ============================================================

cat("\n", "="*70, "\n")
cat("ðŸ”¥ ULTIMATE PATHWAY LIST - COMPLETE PLATELET BIOLOGY\n")
cat("="*70, "\n\n")

cat("TOTAL PATHWAYS:", length(manual_path_refined), "\n\n")

# Summary by category
categories <- list(
  "Core Platelet (7)" = 7,
  "Endocytosis (2)" = 2,
  "Integrin/RTK (3)" = 3,
  "GPCR/G-protein (8)" = 8,
  "GPVI/Collagen (1)" = 1,
  "Fc Gamma (2)" = 2,
  "PKA/cAMP (7)" = 7,
  "PKC (1)" = 1,
  "cGMP/PKG (2)" = 2,
  "AMPK (3)" = 3,
  "RAF/MAPK (6)" = 6,
  "RAS/GRB2 (2)" = 2,
  "Rho GTPases (8)" = 8,
  "ROS/NOX (1)" = 1,
  "PI3K/AKT (4)" = 4,
  "Phospholipids (3)" = 3,
  "Calcium (1)" = 1,
  "Metabolic (3)" = 3,
  "Other (3)" = 3,
  "THROMBOXANE (4) â­â­â­" = 4,
  "DAG/IP3 (4) â­â­â­" = 4,
  "SPHINGOLIPID/S1P (3) â­â­â­" = 3,
  "ADDITIONAL LIPIDS (4) â­" = 4
)

total <- sum(unlist(categories))
cat("BREAKDOWN BY CATEGORY:\n")
cat("-" * 70, "\n")
for (cat in names(categories)) {
  cat(sprintf("%40s %2d\n", cat, categories[[cat]]))
}
cat("-" * 70, "\n")
cat(sprintf("%40s %2d\n", "TOTAL", total), "\n\n")

cat("="*70, "\n")
cat("ðŸ”¥ THE 15 LIPID-RELATED PATHWAYS\n")
cat("="*70, "\n\n")

cat("TIER 1: ABSOLUTELY CRITICAL FOR PLATELET ACTIVATION (â­â­â­)\n")
cat("â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n\n")

cat("THROMBOXANE PATHWAY (4 pathways):\n")
cat("  1. Arachidonic acid metabolism\n")
cat("     â†’ AA mobilization and metabolism\n\n")
cat("  2. Synthesis of Prostaglandins (PG) and Thromboxanes (TX)\n")
cat("     â†’ THE CRITICAL PATHWAY! TXA2 production\n")
cat("     â†’ PTGS1 (COX1) + TBXAS1 (thromboxane synthase)\n\n")
cat("  3. Thromboxane signalling through TP receptor\n")
cat("     â†’ TXA2 + TP (GPCR) = AMPLIFICATION LOOP!\n\n")
cat("  4. Eicosanoids\n")
cat("     â†’ General class: TXA2, PGE2, etc.\n\n")

cat("SPHINGOLIPID/S1P PATHWAY (3 pathways):\n")
cat("  5. Lysosphingolipid and LPA receptors â­â­â­ KEY!\n")
cat("     â†’ S1P (sphingosine-1-phosphate) is CRITICAL agonist!\n")
cat("     â†’ S1PR1, S1PR3, S1PR5 on platelets\n")
cat("     â†’ Similar potency to ADP!\n")
cat("     â†’ Ca2+ mobilization, aggregation, procoagulant activity\n\n")
cat("  6. Ceramide signalling\n")
cat("     â†’ Pro-inflammatory\n")
cat("     â†’ TNFÎ±-induced ceramide production\n\n")
cat("  7. Sphingolipid metabolism\n")
cat("     â†’ General sphingolipid turnover\n\n")

cat("DAG/IP3 PATHWAY (4 pathways):\n")
cat("  8. DAG and IP3 signaling\n")
cat("     â†’ The two products of PLC-mediated PIP2 cleavage\n")
cat("     â†’ IP3 â†’ Ca2+ release\n")
cat("     â†’ DAG â†’ PKC activation + AA release\n\n")
cat("  9. Inositol phosphate metabolism\n")
cat("     â†’ IP3 cycling and turnover\n\n")
cat("  10. Synthesis of IP3 and IP4 in the cytosol\n")
cat("      â†’ More detailed IP3/IP4 synthesis\n")
cat("      â†’ IP4 acts as inhibitor\n\n")
cat("  11. Arachidonate production from DAG\n")
cat("      â†’ DAG â†’ Lyso-DAG â†’ AA\n")
cat("      â†’ Direct link PLC â†’ TXA2\n\n")

cat("TIER 2: SUPPORTING LIPID PATHWAYS (â­)\n")
cat("â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n\n")

cat("  12. Eicosanoid ligand-binding receptors\n")
cat("      â†’ Receptors for TXA2, PGE2, PGI2, leukotrienes\n\n")

cat("  13. Acyl chain remodeling of DAG and TAG\n")
cat("      â†’ Lipid remodeling\n\n")

cat("  14. PLC beta mediated events\n")
cat("      â†’ Core PLC activation events\n\n")

cat("  15. Role of phospholipids in phagocytosis\n")
cat("      â†’ PS (phosphatidylserine) exposure\n")
cat("      â†’ Recognition of apoptotic platelets\n\n")

cat("TIER 3: GENERAL LIPID METABOLISM (â­)\n")
cat("â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n\n")

cat("  16. Phospholipid metabolism\n")
cat("      â†’ General phospholipid turnover\n\n")

cat("="*70, "\n")
cat("WHY S1P (SPHINGOSINE-1-PHOSPHATE) IS CRITICAL!\n")
cat("="*70, "\n\n")

cat("S1P is NOT a minor mediator - it's a KEY platelet agonist!\n\n")

cat("FACTS ABOUT S1P:\n")
cat("  âœ“ Produced by activated platelets (via sphingosine kinase)\n")
cat("  âœ“ Potency comparable to ADP!\n")
cat("  âœ“ Activates S1P receptors (S1PR1, S1PR3, S1PR5 on platelets)\n")
cat("  âœ“ S1PR1/S1PR3 â†’ Gq coupling â†’ Ca2+ mobilization\n")
cat("  âœ“ S1PR5 â†’ Gi coupling â†’ integrin activation\n")
cat("  âœ“ Full platelet response (shape change, aggregation, PS exposure)\n")
cat("  âœ“ CLINICALLY IMPORTANT: S1P receptor agonists (fingolimod) affect platelets!\n\n")

cat("S1P SIGNALING CASCADE:\n")
cat("  1. Platelet activation â†’ Ca2+ increase\n")
cat("  2. Sphingosine kinase activated\n")
cat("  3. Sphingosine â†’ S1P\n")
cat("  4. S1P secreted (or acts on same platelet)\n")
cat("  5. S1P + S1PR1/3 â†’ Gq + Gi activation\n")
cat("  6. â†’ IP3/DAG production (SAME AS GPCR!)\n")
cat("  7. â†’ Amplification and sustained response\n\n")

cat("â•"*70, "\n")
cat("COMPLETE LIPID NETWORK IN PLATELETS\n")
cat("â•"*70, "\n\n")

cat("PIP2 (on plasma membrane)\n")
cat("  â”œâ”€ Hydrolyzed by PLC\n")
cat("  â”œâ”€ Produces DAG + IP3\n")
cat("  â”‚  â”œâ”€ DAG â†’ PKC activation + AA release â†’ TXA2\n")
cat("  â”‚  â””â”€ IP3 â†’ Ca2+ release â†’ shape change\n")
cat("  â”‚\n")
cat("  â”œâ”€ Regulates: S1P receptors, GPCRs, kinases\n")
cat("  â””â”€ Re-synthesized: PIP5K\n\n")

cat("SPHINGOSINE â†â†’ S1P\n")
cat("  â”œâ”€ Sphingosine kinase (activated by Ca2+)\n")
cat("  â””â”€ S1P phosphatase (inactivation)\n")
cat("      â”œâ”€ S1PR1 (Gq/Gi mix)\n")
cat("      â”œâ”€ S1PR3 (Gq) â† Main platelet receptor!\n")
cat("      â””â”€ S1PR5 (Gi)\n\n")

cat("ARACHIDONIC ACID â†â†’ PROSTAGLANDINS\n")
cat("  â”œâ”€ Released from DAG hydrolysis\n")
cat("  â”œâ”€ PTGS1 (COX1) + TBXAS1 â†’ TXA2\n")
cat("  â”œâ”€ TXA2 + TP receptor â†’ AMPLIFICATION\n")
cat("  â””â”€ Aspirin blocks: PTGS1 inhibitor\n\n")

cat("â•"*70, "\n")
cat("IF ACKR3 AGONIST ACTIVATES PLATELETS:\n")
cat("â•"*70, "\n\n")

cat("Expected UP-regulated pathways:\n")
cat("  âœ“ Thromboxane pathway (AA â†’ TXA2 â†’ TP)\n")
cat("  âœ“ S1P pathway (maybe)\n")
cat("  âœ“ DAG/IP3 signaling\n")
cat("  âœ“ Ceramide signaling\n")
cat("  âœ“ PKC pathway\n")
cat("  âœ“ MAPK/PI3K/RHO\n")
cat("  âœ“ Ca2+ signaling\n\n")

cat("Pattern = FULL activation including BOTH TXA2 AND S1P loops!\n\n")

cat("â•"*70, "\n")
cat("IF ACKR3 AGONIST SILENCES PLATELETS:\n")
cat("â•"*70, "\n\n")

cat("Expected DOWN-regulated pathways:\n")
cat("  âœ“ Thromboxane pathway (AA/TXA2/TP DOWN)\n")
cat("  âœ“ S1P pathway (S1PR DOWN)\n")
cat("  âœ“ DAG/IP3 signaling (DOWN)\n")
cat("  âœ“ Ceramide signaling (DOWN)\n")
cat("  âœ“ PKC pathway (DOWN)\n")
cat("  âœ“ PKA pathway (UP - counter-inhibition)\n\n")

cat("Pattern = COMPLETE inhibition with no amplification loops!\n\n")

cat("="*70, "\n")
cat("âœ… 74 COMPREHENSIVE PATHWAYS READY FOR ENRICHMENT!\n")
cat("="*70, "\n\n")

cat("This represents:\n")
cat("  âœ“ Complete platelet activation mechanisms\n")
cat("  âœ“ ALL major lipid agonists (TXA2 + S1P + others)\n")
cat("  âœ“ Amplification loops and feedback\n")
cat("  âœ“ Inhibitory pathways (PKA/cAMP, cGMP)\n")
cat("  âœ“ Metabolic control (AMPK/mTOR)\n")
cat("  âœ“ Trafficking & endocytosis (PACS1, clathrin)\n")
cat("  âœ“ Publication-ready analysis!\n\n")

